Nano Oncology is categorized under Noncommercial Research Organizations in Madison, WI and active since 2010.
Nano Oncology was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Thomas Primiano Phd at the company’s single location by writing to 5520 Nobel Drive # 160, Madison, Wisconsin WI 53711 or by phoning (608) 441-5680. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Nano Oncology |
| Contact Person: | Thomas Primiano Phd |
| Address: | 5520 Nobel Drive # 160, Madison, Wisconsin 53711 |
| Phone Number: | (608) 441-5680 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Research Organizations |
| SIC Code: | 8733 |
| NAICS Code: | 6211110 |
| Share This Business: |
Nano Oncology was started in 2010 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Thomas Primiano Phd for inquiries that concern Nano Oncology by calling the company number (608) 441-5680, as your correspondence is most welcome. Additionally, the physical location of the single location of Nano Oncology can be found at the coordinates 42.995825,-89.424362 as well as the street address 5520 Nobel Drive # 160 in Madison, Wisconsin 53711.
For its online presence, you may visit Nano Oncology’s website at and engage with its social media outlets through on Twitter and on Facebook.